Strategic Partnerships OGV collaborates with Israeli biotech and cannabis leaders, signaling openness to B2B partnerships, distribution deals, and co-development opportunities that can be pitched to potential suppliers, manufacturers, or research partners in the US market.

Pharma-Grade Positioning The company emphasizes pharmaceutical manufacturing standards and scientific innovation, making them a credible partner for contract manufacturing, quality assurance services, and regulatory consulting for US-based wellness brands seeking compliant cannabis solutions.

Global to US Focus OGV specializes in transferring Israeli cannabis innovations to the US, suggesting sales opportunities in import partnerships, technology licensing, and joint ventures that leverage cross-border capabilities and US market access.

Early Growth Signals With leadership hires and a launch of Tikva in 2019, there is a narrative of growth and market expansion that can be leveraged to approach investors, distributors, and retail networks seeking proven momentum and scalable product lines.

Lean Foundation Current employee count is 0-1 with revenue under $1M, indicating a high-need, high-potential sales targeting early-stage collaboration, distribution agreements, and pilot programs to accelerate revenue and scale operations.